Hypoxia drives hematopoiesis with the enhancement of T lineage through eliciting arterial specification of hematopoietic endothelial progenitors from hESC
DOI: 10.1186/s13287-022-02967-0
Authors: Ning Wang; Chuxin Chen; Yang Cheng; Yingjie Fu; Zhiyong Zhong; Yu Yang; Ling Lv; Honglin Chen; Jian Huang; Yuyou Duan
Step 1: iPSC/ESC maintainance
day 0 ~ 1 (duration missing in database; assumed 1 day)
culture “adherent” human ESC in “DMEM/F12”. For ECM, use “Fibroblast” at “N/A” “N/A”. Medium should contain factors shown in the following table.
| concentration | unit | |
|---|---|---|
| KSR | 20 | % |
| Glutamine | 0.001 | mol/l |
| NEAA | 1 | % |
| PSA | 1 | % |
| 2-mercaptoethanol | 1.0e-4 | mol/l |
| FGF | 1.0e-5 | g/l |
Ideally, “ESC” should be obtained at the end of culture.
Step 2: mesoderm 1
day 1 ~ 5
culture “spheroid” human ESC in “APEL medium” for “4” days. Medium should contain factors shown in the following table, and should be changed once in “4” days.
| concentration | unit | |
|---|---|---|
| BMP4 | 2.0e-5 | g/l |
| Activin A | 1.0e-5 | g/l |
| VEGF | 2.5e-5 | g/l |
| SCF | 1.0e-5 | g/l |
| FGF | 1.0e-5 | g/l |
| CHIR90021 | 3.0e-6 | mol/l |
| SB431542 | 4.0e-6 | mol/l |
| Y27632 | 1.0e-5 | mol/l |
Ideally, “mesoderm” should express “CDX4”, “KDR”, “BMP4”, “TBXT”, “SOX17”, “CD56”, “HIF-1alpha” at the end of culture.
Step 3: mesoderm 2
day 5 ~ 8
culture “spheroid” human mesoderm in “APEL medium” for “3” days. Medium should contain factors shown in the following table, and should be changed once in “3” days.
| concentration | unit | |
|---|---|---|
| BMP4 | 2.0e-5 | g/l |
| VEGF | 5.0e-5 | g/l |
| FGF | 1.0e-5 | g/l |
| SCF | 1.0e-5 | g/l |
| IGF2 | 1.5e-5 | g/l |
Ideally, “HEP” should express “PECAM1”, “CD34”, “CDH5” at the end of culture.
Step 4: endothelial 1
day 8 ~ 12
culture “adherent” human mesoderm in “APEL medium” for “4” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “4” days.
| concentration | unit | |
|---|---|---|
| IL-3 | 5.0e-5 | g/l |
| SCF | 1.0e-4 | g/l |
| FLT3L | 2.5e-5 | g/l |
| VEGF | 5.0e-5 | g/l |
| IL-6 | 2.5e-5 | g/l |
| TPO | 2.5e-5 | g/l |
| EPO | 3000 | U/l |
| FGF | 1.0e-5 | g/l |
| IGF2 | 2.0e-5 | g/l |
Ideally, “HEP” should be obtained at the end of culture. Ideally, “HEP” should express “PECAM1”, “CD34”, “CDH5”, “CDH5”, “SOX17”, “DLL4”, “NOTCH1”, “EPHB4” at the end of culture.
Step 5: endothelial 2
day 12 ~ 16
culture “adherent” human HEP in “APEL medium” for “4” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “4” days.
| concentration | unit | |
|---|---|---|
| VEGF | 5.0e-5 | g/l |
| SCF | 1.0e-4 | g/l |
| IL-6 | 2.5e-5 | g/l |
| TPO | 2.5e-5 | g/l |
| FLT3L | 2.5e-5 | g/l |
| FGF | 1.0e-5 | g/l |
| IGF2 | 2.0e-5 | g/l |
Ideally, “HEP” should express “PECAM1”, “CD34”, “CDH5”, “RUNX1”, “DLL4”, “NOTCH1”, “VEGF”, “NR2F2”, “CDH5”, “PTPRC” at the end of culture. Ideally, “HPC” should express “CD34”, “PTPRC”, “HIF-1alpha”, “GATA1” at the end of culture.